Citations (92)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Hee-Ryung Cho, Su Kang Kim, Hee-Kyeong Lim, Hae Jeong Park, Joo-Ho Chung & Mu-Hyoung Lee. (2013) Association study between nonsense polymorphism (rs2039381, Gln71Stop) of Interferon-ε and susceptibility to vitiligo in Korean population. Immunological Investigations 42:5, pages 423-430.
Read now
Read now
E. Helen Kemp. (2004) Autoantibodies as Diagnostic and Predictive Markers of Vitiligo. Autoimmunity 37:4, pages 287-290.
Read now
Read now
Christian Beisland & Dag Sollesnes Holsen. (2004) Vitiligo—an autoimmune side‐effect of intravesical bacillus Calmette–Guérin instillation?. Scandinavian Journal of Urology and Nephrology 38:2, pages 182-183.
Read now
Read now
Articles from other publishers (89)
Khadeejeh AL-smadi, Mohammad Imran, Vania R. Leite-Silva & Yousuf Mohammed. (2023) Vitiligo: A Review of Aetiology, Pathogenesis, Treatment, and Psychosocial Impact. Cosmetics 10:3, pages 84.
Crossref
Crossref
Radwa Tirana, Doa Othman, Dalia Gad, Menan Elsadek & Mohamed A. Baky Fahmy. (2022) Pigmentary complications after non-medical male circumcision. BMC Urology 22:1.
Crossref
Crossref
Alokananda ChakrabortyPriyanka PallapoluSeelamneni ThulasammaLahari KunaShravan Kumar GhaliKaiser JamilGhazala JavedMunawwar Husain Kazmi. (2022) Genetic variations in NLRP1 and Glutathione S-Transferase are associated with Generalized Vitiligo of Phlegmatic Clinical Phenotypes in Unani Medicine Philosophy of South Indian Population. Research Journal of Pharmacy and Technology, pages 2221-2227.
Crossref
Crossref
Safa Faraj, Elizabeth Helen Kemp & David John Gawkrodger. (2022) Patho-immunological mechanisms of vitiligo: the role of the innate and adaptive immunities and environmental stress factors. Clinical and Experimental Immunology 207:1, pages 27-43.
Crossref
Crossref
Wafaa A. Shehata, Alaa Maraee, Marwa Mehesin, Nermin Tayel & Rania Azmy. (2020) Genetic polymorphism of liver X receptor gene in vitiligo: Does it have an association?. Journal of Cosmetic Dermatology 20:6, pages 1906-1914.
Crossref
Crossref
U.Yu. Sabirov, A.S. Yakubova & S.S. Arifov. (2021) Clinical features of segmental and non-segmental vitiligo. Klinicheskaya dermatologiya i venerologiya 20:6, pages 140.
Crossref
Crossref
Noha Nabil Doghaim, Rania Ahmed El‐Tatawy, Mayada A. Ismail, Dareen Abdelaziz Mohammed Ali & Yasmina Ahmed El Attar. (2019) Study the effect of erbium:YAG laser plus topical 5‐flurouracil in stable vitiligo resistant to NB‐UVB phototherapy. Journal of Cosmetic Dermatology 19:1, pages 122-130.
Crossref
Crossref
Ling Li, Qiushuang Ma & Haiyan Li. (2019)
Effect of vitiligo treatment using compound glycyrrhizin combined with fractional carbon dioxide laser and topical triamcinolone acetonide on serum interleukin-17 and tissue growth factor-
β
levels
. Journal of International Medical Research 47:11, pages 5623-5631.
Crossref
Crossref
YunJie Zhang, Hui Lin, XiaoJuan Guo & XianBiao Zou. (2018) A case series pilot study on the combination of 5-aminolevulinic acid and photodynamic therapy (ALA-PDT) for treatment of vitiligo. Anais Brasileiros de Dermatologia 93:4, pages 539-545.
Crossref
Crossref
Mario Vaccaro, Natasha Irrera, Giuseppina Cutroneo, Giuseppina Rizzo, Federico Vaccaro, Giuseppe Anastasi, Francesco Borgia, Serafinella Cannavò, Domenica Altavilla & Francesco Squadrito. (2017) Differential Expression of Nitric Oxide Synthase Isoforms nNOS and iNOS in Patients with Non-Segmental Generalized Vitiligo. International Journal of Molecular Sciences 18:12, pages 2533.
Crossref
Crossref
Enass S. Mohamed, Eman A. Said, Doaa S. Sayed, Sara M. Awad & Marwa H. Ahmed. (2017) Auditory system dysfunction in patients with vitiligo: is it a part of a systemic autoimmune process?. The Egyptian Journal of Otolaryngology 33:3, pages 594-602.
Crossref
Crossref
Ragıp Ertaş, Kemal Özyurt, Atıl Avcı, Sule Ketenci Ertas & Mustafa Atasoy. (2017) Case Report: Behçet’s disease accompanied with vitiligo. F1000Research 6, pages 310.
Crossref
Crossref
Rashmi Sarkar, Sumit Sethi & Anjali Madan. 2017. Melasma and Vitiligo in Brown Skin. Melasma and Vitiligo in Brown Skin
191
196
.
Aleksandra Krzewska & Iwona Ben-Skowronek. (2016) Effect of Associated Autoimmune Diseases on Type 1 Diabetes Mellitus Incidence and Metabolic Control in Children and Adolescents. BioMed Research International 2016, pages 1-12.
Crossref
Crossref
R Dey-Rao & A A Sinha. (2015) Interactome analysis of gene expression profile reveals potential novel key transcriptional regulators of skin pathology in vitiligo. Genes & Immunity 17:1, pages 30-45.
Crossref
Crossref
Euphemia W. Mu, Brandon E. Cohen & Seth J. Orlow. (2015) Early-onset childhood vitiligo is associated with a more extensive and progressive course. Journal of the American Academy of Dermatology 73:3, pages 467-470.
Crossref
Crossref
Kostas Kakleas, Alexandra Soldatou, Feneli Karachaliou & Kyriaki Karavanaki. (2015) Associated autoimmune diseases in children and adolescents with type 1 diabetes mellitus (T1DM). Autoimmunity Reviews 14:9, pages 781-797.
Crossref
Crossref
Ali Murat Tatli, Ali Ayberk Besen, Mehmet Emin Kalender, Mukremin Uysal, Deniz Asian, Sema Sezgin Goksu, Seyda Gulenay Gunduz & Hasan Senol Coskun. (2015) Association of Vitiligo and Response in Patients with Metastatic Malignant Melanoma on Temozolomide. Tumori Journal 101:2, pages e67-e69.
Crossref
Crossref
Qingli Gong, Xue Li, Jie Sun, Gaozhong Ding, Meihua Zhou, Wene Zhao & Yan Lu. (2015) The effects of calcipotriol on the dendritic morphology of human melanocytes under oxidative stress and a possible mechanism: Is it a mitochondrial protector?. Journal of Dermatological Science 77:2, pages 117-124.
Crossref
Crossref
Gulcan Saylam Kurtipek, Fatma Gökşin Cihan, Şule Erayman Demirbaş & Arzu Ataseven. (2015) The Frequency of Autoimmune Thyroid Disease in Alopecia Areata and Vitiligo Patients. BioMed Research International 2015, pages 1-4.
Crossref
Crossref
David Choi, Prescilia Isedeh & Iltefat H. Hamzavi. (2014) Vitiligo. Journal of the Egyptian Womenʼs Dermatologic Society 11:3, pages 145-158.
Crossref
Crossref
Torello Lotti, Matteo Zanardelli & Angelo Massimiliano D’Erme. (2014) Vitiligo: what’s new in the psycho-neuro-endocrine-immune connection and related treatmentsVitiligo: Was gibt es Neues im Psycho-Neuro- Endokrino-Immunologischen Zusammenhang und bei verwandten Therapien?. Wiener Medizinische Wochenschrift 164:13-14, pages 278-285.
Crossref
Crossref
In Kyung JeonChul Jong Park, Mu-Hyoung LeeDong Youn LeeHee Young Kang, Seung Kyung HannGwang Seong ChoiHee Jung LeeTae Heung KimAi-Young LeeSang Ho Oh. (2014) A Multicenter Collaborative Study by the Korean Society of Vitiligo about Patients' Occupations and the Provoking Factors of Vitiligo. Annals of Dermatology 26:3, pages 349.
Crossref
Crossref
José Antonio Del Río, Licinio Díaz, David García-Bernal, Miguel Blanquer, Ana Ortuño, Enrique Correal & José María Moraleda. 2014.
145
195
.
Karin U. Schallreuter. 2014. Systems Biology of Free Radicals and Antioxidants. Systems Biology of Free Radicals and Antioxidants
3697
3736
.
Abdellatif Bouayad, L. Benzekri, S. Hamada, C. Brick, B. Hassam & M. Essakalli. (2013) Association of HLA alleles and haplotypes with vitiligo in Moroccan patients: a case–control study. Archives of Dermatological Research 305:10, pages 925-932.
Crossref
Crossref
Lei Ma, Hai-Bo Xue, Xiu-Hao Guan, Chun-Mei Shu, Yu-Jie Zhang, Jun-Hua Zhang & Rong-Zhen An. (2013) Relationship of macrophage migration inhibitory factor levels in PBMCs, lesional skin and serum with disease severity and activity in vitiligo vulgaris. Brazilian Journal of Medical and Biological Research 46:5, pages 460-464.
Crossref
Crossref
A A Larina & E A Troshina. (2013) Autoimmune diseases associated with type 1 diabetes mellitus: possible interplay. Problems of Endocrinology 59:1, pages 35-43.
Crossref
Crossref
Siavash Toosi, Seth J. Orlow & Prashiela Manga. (2012) Vitiligo-Inducing Phenols Activate the Unfolded Protein Response in Melanocytes Resulting in Upregulation of IL6 and IL8. Journal of Investigative Dermatology 132:11, pages 2601-2609.
Crossref
Crossref
V V ZHULMINA, YE N KOLOGRIVOVA, P N PESTEREV & N P LABZOVSKAYA. (2012) Functional characteristics of macrophages in the vitiligo foci. Vestnik dermatologii i venerologii 88:5, pages 52-55.
Crossref
Crossref
G. Stinco, C. Buligan, F. Grimaldi, F. Valent & P. Patrone. (2012) Serological screening for autoimmune polyendocrine syndromes in patients with vitiligo. Journal of the European Academy of Dermatology and Venereology 26:8, pages 1041-1042.
Crossref
Crossref
Jakub SawickiSanjay SiddhaCheryl Rosen. (2012) Vitiligo and Associated Autoimmune Disease: Retrospective Review of 300 Patients. Journal of Cutaneous Medicine and Surgery 16:4, pages 261-266.
Crossref
Crossref
Iraj Esfandiarpour & Saeedeh Farajzadeh. (2012) Clinical characteristics of late-onset vitiligo in an Iranian population. Dermatologica Sinica 30:2, pages 43-46.
Crossref
Crossref
Ene Reimann, Külli Kingo, Maire Karelson, Paula Reemann, Ulvi Loite, Helen Sulakatko, Maris Keermann, Kristi Raud, Kristi Abram, Eero Vasar, Helgi Silm & Sulev Kõks. (2012) The mRNA expression profile of cytokines connected to the regulation of melanocyte functioning in vitiligo skin biopsy samples and peripheral blood mononuclear cells. Human Immunology 73:4, pages 393-398.
Crossref
Crossref
K.V.S. Hari Kumar, Sai Priya, Ruchita Sharma, Umesh Kapoor, Mandeep Saini & Yudhveer S. Bisht. (2012) Autoimmune Thyroid Disease in Patients With Vitiligo: Prevalence Study in India. Endocrine Practice 18:2, pages 194-199.
Crossref
Crossref
P. Senet & O. Chosidow. (2012) Manifestaciones cutaneomucosas de la diabetes. EMC - Dermatología 46:1, pages 1-8.
Crossref
Crossref
Ji Young Kim, Jae Yong Shin, Miri Kim, Seung-Kyung Hann & Sang Ho Oh. (2012) Expression of cytosolic NADP+-dependent isocitrate dehydrogenase in melanocytes and its role as an antioxidant. Journal of Dermatological Science 65:2, pages 118-125.
Crossref
Crossref
S. O. Niang, Maodo Ndiaye, Fatimata Ly, Moussa Diallo, Sonia Bouksani, Assane Diop, Boubacar Ahy Diatta, Mame Thierno Dieng & Assane Kane. (2012) The Vitiligo in Senegal. ISRN Dermatology 2012, pages 1-3.
Crossref
Crossref
Anne M. Bowcock & Marcelo Fernandez-Vina. (2012) Targeting Skin: Vitiligo and Autoimmunity. Journal of Investigative Dermatology 132:1, pages 13-15.
Crossref
Crossref
Brea Prindaville & Scott A Rivkees. (2011) Incidence of vitiligo in children with Graves' disease and Hashimoto's thyroiditis. International Journal of Pediatric Endocrinology 2011:1.
Crossref
Crossref
Abeer Abdel Khalik Mohamed & Shereen F.M. El-Saman. (2011) Light and electron microscopic studies of the effect of combined topical calcipotriol and PUVA therapy on patients with vitiligo. The Egyptian Journal of Histology 34:1, pages 15-27.
Crossref
Crossref
Daniela Pereira Antelo, Absalom Lima Filgueira & José Marcos Telles Cunha. (2011)
Reduction of skin‐homing cytotoxic T cells (CD8
+
–CLA
+
) in patients with vitiligo
. Photodermatology, Photoimmunology & Photomedicine 27:1, pages 40-44.
Crossref
Crossref
Sibel Uncu, Savaş Yaylı, Sevgi Bahadır, Ayşenur Ökten & Köksal Alpay. (2011) Relevance of autoimmune thyroiditis in children and adolescents with vitiligo. International Journal of Dermatology 50:2, pages 175-179.
Crossref
Crossref
Pedro Redondo, Ana Giménez de Azcarate, Laura Marqués, María García-Guzman, Enrique Andreu & Felipe Prósper. (2011) Amniotic Membrane as a Scaffold for Melanocyte Transplantation in Patients with Stable Vitiligo. Dermatology Research and Practice 2011, pages 1-6.
Crossref
Crossref
SB Cho, JH Kim, S Cho, JM Park, YK Park & SH Oh. (2011) Vitiligo in children and adolescents: association with thyroid dysfunction. Journal of the European Academy of Dermatology and Venereology 25:1, pages 64-67.
Crossref
Crossref
P. Senet & O. Chosidow. (2011) Manifestations cutanéomuqueuses du diabète. EMC - Dermatologie 6:4, pages 1-8.
Crossref
Crossref
Karin U. Schallreuter. 2011. Autoimmune Diseases of the Skin. Autoimmune Diseases of the Skin
435
461
.
P. Agretti, G. De Marco, D. Sansone, C. Betterle, G. Coco, A. Dimida, E. Ferrarini, A. Pinchera, P. Vitti & M. Tonacchera. (2014) Patients affected by vitiligo and autoimmune diseases do not show antibodies interfering with the activity of the melanocortin 1 receptor. Journal of Endocrinological Investigation 33:11, pages 784-788.
Crossref
Crossref
D V Proshutinskaya, V A Volnukhin, O R Katunina & A V Rezaikina. (2010) On the role of dendritic cells in the pathogenesis of vitiligo. Vestnik dermatologii i venerologii 86:4, pages 28-32.
Crossref
Crossref
Arpita Choudhury, Philip L. Cohen & Robert A. Eisenberg. (2010) B cells require “nurturing” by CD4 T cells during development in order to respond in chronic graft-versus-host model of systemic lupus erythematosus. Clinical Immunology 136:1, pages 105-115.
Crossref
Crossref
Jordi Rex Cavallé. (2010) Estado actual del tratamiento del vitíligo basado en la evidencia. Piel 25:5, pages 246-251.
Crossref
Crossref
P. Quaglino, F. Marenco, S. Osella-Abate, N. Cappello, M. Ortoncelli, B. Salomone, M.T. Fierro, P. Savoia & M.G. Bernengo. (2010) Vitiligo is an independent favourable prognostic factor in stage III and IV metastatic melanoma patients: results from a single-institution hospital-based observational cohort study. Annals of Oncology 21:2, pages 409-414.
Crossref
Crossref
P. Senet & O. Chosidow. (2010) Manifestations cutanéomuqueuses du diabète. EMC - Endocrinologie - Nutrition 7:3, pages 1-7.
Crossref
Crossref
A. Moreland & P. Kohl. 2010. Atlas of Sexually Transmitted Diseases and AIDS. Atlas of Sexually Transmitted Diseases and AIDS
1
23
.
Marpe Bam & Tamishraha Bagchi. (2009) MART-1 transcript is absent in PBMCs from Vitiligo patients. Open Life Sciences 4:4, pages 528-535.
Crossref
Crossref
Mohamed M. A. E. L. Salem, Mohammad Shalbaf, Nicholas C. J. Gibbons, Bhaven Chavan, J. M. Thornton & Karin U. Schallreuter. (2009)
Enhanced DNA binding capacity on up‐regulated epidermal wild‐type p53 in vitiligo by H
2
O
2
‐mediated oxidation: a possible repair mechanism for DNA damage
. The FASEB Journal 23:11, pages 3790-3807.
Crossref
Crossref
M. Bam & T. Bagchi. (2009) Absence of Tyrosinase-Related Protein-2/Dopachrome Tautomerase Transcripts in PBMCs from Vitiligo Patients. Scandinavian Journal of Immunology 69:4, pages 366-373.
Crossref
Crossref
Lucas S.C. Nogueira, Pedro C.Q. Zancanaro & Roberto D. Azambuja. (2009) Vitiligo e emoções. Anais Brasileiros de Dermatologia 84:1, pages 41-45.
Crossref
Crossref
Rafael Falabella & Maria I. Barona. (2009) Update on skin repigmentation therapies in vitiligo. Pigment Cell & Melanoma Research 22:1, pages 42-65.
Crossref
Crossref
Han Kyoung ChoLucy Youngmin EunJi-Sun SongWon Hyoung KangByung In Ro. (2009) A Case of Vitiligo after Kawasaki's Disease. Annals of Dermatology 21:1, pages 75.
Crossref
Crossref
E. Helen Kemp. (2008) Commentary 1. Experimental Dermatology 17:2, pages 150-151.
Crossref
Crossref
Lübeck Ralf Paus, K. U. Schallreuter, P. Bahadoran, M. Picardo, A. Slominski, Y. E. Elassiuty, E. H. Kemp, C. Giachino, J. B. Liu, R. M. Luiten, T. Lambe, I. C. Le Poole, I. Dammak, H. Onay, M. A. Zmijewski, M. L. Dell’Anna, M. P. Zeegers, R. J. Cornall, R. Paus, J. P. Ortonne & W. Westerhof. (2008) Vitiligo pathogenesis: autoimmune disease, genetic defect, excessive reactive oxygen species, calcium imbalance, or what else?. Experimental Dermatology 17:2, pages 139-160.
Crossref
Crossref
Umar D. Khan. (2007) Bilateral Areoleor Depigmentation After Augmentation Mammoplasty: A Case Report and Literature Search. Aesthetic Plastic Surgery 32:1, pages 143-146.
Crossref
Crossref
Sharon Baum, Aviv Barzilai & Henri Trau. 2008. Diagnostic Criteria in Autoimmune Diseases. Diagnostic Criteria in Autoimmune Diseases
353
358
.
R??gis P Radermecker, G??rald E Pi??rard & Andr?? J Scheen. (2007) Lipodystrophy Reactions to Insulin. American Journal of Clinical Dermatology 8:1, pages 21-28.
Crossref
Crossref
Peter D. Boasberg, Dave S.B. Hoon, Lawrence D. Piro, Maureen A. Martin, Akhide Fujimoto, Timothy S. Kristedja, Sandeep Bhachu, Xing Ye, Regina R. Deck & Steven J. O'Day. (2006) Enhanced Survival Associated with Vitiligo Expression during Maintenance Biotherapy for Metastatic Melanoma. Journal of Investigative Dermatology 126:12, pages 2658-2663.
Crossref
Crossref
P. Amerio, M. Tracanna, P. De Remigis, C. Betterle, L. Vianale, M. E. Marra, D. Di Rollo, R. Capizzi, C. Feliciani & A. Tulli. (2006) Vitiligo associated with other autoimmune diseases: polyglandular autoimmune syndrome types 3B + C and 4. Clinical and Experimental Dermatology 31:5, pages 746-749.
Crossref
Crossref
Jean L. Bolognia, James J. Nordlund, Jean‐Paul Ortonne & I. Caroline Le Poole. 2006. The Pigmentary System. The Pigmentary System
551
598
.
Bärbel Greve, Christian Raulin & Edda Fischer. (2006) Excimer laser treatment of vitiligo - critical retrospective assessment of own results and literature overview. Journal der Deutschen Dermatologischen Gesellschaft 4:1, pages 32-40.
Crossref
Crossref
Paula Clare Eves, Alison J. Beck, Alex G. Shard & Sheila Mac Neil. (2005) A chemically defined surface for the co-culture of melanocytes and keratinocytes. Biomaterials 26:34, pages 7068-7081.
Crossref
Crossref
S Farrokhi, M Hojjat-Farsangi, MK Noohpisheh, R Tahmasbi & N Rezaei. (2005) Assessment of the immune system in 55 Iranian patients with vitiligo. Journal of the European Academy of Dermatology and Venereology 19:6, pages 706-711.
Crossref
Crossref
I Cantón, S Akhtar, N G Gavalas, D J Gawkrodger, A Blomhoff, P F Watson, A P Weetman & E H Kemp. (2005) A single-nucleotide polymorphism in the gene encoding lymphoid protein tyrosine phosphatase (PTPN22) confers susceptibility to generalised vitiligo. Genes & Immunity 6:7, pages 584-587.
Crossref
Crossref
Talia Kakourou, Christina Kanaka-Gantenbein, Anna Papadopoulou, Eirini Kaloumenou & George P. Chrousos. (2005) Increased prevalence of chronic autoimmune (Hashimoto's) thyroiditis in children and adolescents with vitiligo. Journal of the American Academy of Dermatology 53:2, pages 220-223.
Crossref
Crossref
Pablo Almeida, Leopoldo Borrego, Julio Rodríguez-López, Dunia Luján, Daniel Cameselle & Buenaventura Hernández. (2005) Vitíligo. Tratamiento de 12 casos con tacrolimus tópico. Actas Dermo-Sifiliográficas 96:3, pages 159-163.
Crossref
Crossref
Yarí E. Marín, Jin Namkoong, Seung-Shick Shin, Jason Raines, Kurt Degenhardt, Eileen White & Suzie Chen. (2005) Grm5 expression is not required for the oncogenic role of Grm1 in melanocytes. Neuropharmacology 49, pages 70-79.
Crossref
Crossref
AB Bong, H Gollnick & MP Schon. (2004) Treatment of vitiligo with topical imiquimod. Journal of the European Academy of Dermatology and Venereology 18:6, pages 741-742.
Crossref
Crossref
Wenyong Li, Weidong Yu, Qun Dong, Ping Wang & Qingxuan Chen. (2004) A complex prescription for vitiligo activates mitochondrial ATP synthase-6 expression in B-16 murine melanoma cells. Journal of Ethnopharmacology 92:2-3, pages 193-196.
Crossref
Crossref
Adam Z. Kawalek, James M. Spencer & Robert G. Phelps. (2004) Combined Excimer Laser and Topical Tacrolimus for the Treatment of Vitiligo: A Pilot Study. Dermatologic Surgery 30:2, pages 130-135.
Crossref
Crossref
Kamer Gunduz, Gunseli Ozturk, Ender Terzioglu & Filiz Sebik. (2014) T Cell Subpopulations and IL‐2R in Vitiligo. The Journal of Dermatology 31:2, pages 94-97.
Crossref
Crossref
Jiménez Puya Rafael, Galán Gutiérrez Manuel, Vélez Antonio & Moreno José Carlos. (2004) Widespread vitiligo after erythroderma caused by photosensitivity to flutamide. Contact Dermatitis 50:2, pages 98-100.
Crossref
Crossref
ADAM Z. KAWALEK, JAMES M. SPENCER & ROBERT G. PHELPS. (2004) Combined Excimer Laser and Topical Tacrolimus for the Treatment of Vitiligo. Dermatologic Surgery 30:2, pages 130-135.
Crossref
Crossref
Mark R. Burge & J. David Carey. (2004) Vitiligo Associated With Subcutaneous Insulin Lispro Infusion in Type 1 Diabetes. Diabetes Care 27:1, pages 275-276.
Crossref
Crossref
Rochelle L. Mandelcorn-Monson, Neil H. Shear, Eddy Yau, Suryaprakash Sambhara, Brian H. Barber, David Spaner & Mark A. DeBenedette. (2003) Cytotoxic T Lymphocyte Reactivity to gp100, MelanA/MART-1, and Tyrosinase, in HLA-A2-Positive Vitiligo Patients. Journal of Investigative Dermatology 121:3, pages 550-556.
Crossref
Crossref
G Leone, P Iacovelli, A Paro Vidolin & M Picardo. (2003) Monochromatic excimer light 308 nm in the treatment of vitiligo: a pilot study. Journal of the European Academy of Dermatology and Venereology 17:5, pages 531-537.
Crossref
Crossref
Katia Ongenae, Nanny Van Geel & Jean-Marie Naeyaert. (2003) Evidence for an Autoimmune Pathogenesis of Vitiligo. Pigment Cell Research 16:2, pages 90-100.
Crossref
Crossref
G ZETTINIG, A TANEW, G FISCHER, W MAYR, R DUDCZAK & M WEISSEL. (2003) Autoimmune diseases in vitiligo: do anti-nuclear antibodies decrease thyroid volume?. Clinical and Experimental Immunology 131:2, pages 347-354.
Crossref
Crossref
S. Benomor, P. Senet & O. Chosidow. (2003) Manifestaciones mucocutáneas de la diabetes. EMC - Dermatología 37:1, pages 1-6.
Crossref
Crossref
Ronit ElhasidReuven BergmanAmos Etzioni. (2002) Autoimmunity in severe combined immunodeficiency (SCID). Blood 100:7, pages 2677-2678.
Crossref
Crossref
Alberto Falorni, Stefano Laureti & Fausto Santeusanio. (2002) Autoantibodies in autoimmune polyendocrine syndrome type II. Endocrinology and Metabolism Clinics of North America 31:2, pages 369-389.
Crossref
Crossref